New Hope is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

PharmaNutrients Unveils Patent-pending Business Method Delivering Faster and Easier Route to Market For Clients

CHICAGO, IL (May 20, 2005) – PharmaNutrients, a leading research and development company and supplier of proprietary, science-based nutritional ingredients, is introducing a new patent-pending business method to help clients minimize new product development risks and time to market.

This comprehensive turnkey system provides clients the use of patents, FDA-filed structure-function claims, scientific substantiation, and a library of intellectual property. Additionally, branding, packaging and a wealth of marketing materials including consumer websites, collateral and print are provided to help launch new products and build strong brands.

PharmaNutrients’ revolutionary business system has many benefits. It reduces time to launch and minimizes product development risks by addressing major internal issues within clients’ regulatory, science, marketing and manufacturing departments.

“Our unique approach of providing an ingredient with all the essential elements for a new product launch is unlike any other in our industry,” explained Mark Nottoli, President and founder of PharmaNutrients. “By integrating all of the elements of support into one unique, patent-pending business system, we assist our clients throughout their product development and market introduction phases.”

The first client-consumer brands to benefit from PharmaNutrients’ business method are CLA Tone™ with CLA One® DG and CLA Omega™ with Omegilin™. These ready-to-market turnkey products incorporate all of the patent-pending system features (view an example at “These products represent new opportunities in CLA, and our system allows clients to take advantage of them with a minimal level of risk,” stated Nottoli.

About PharmaNutrients, Inc.:

Dedicated to creating products to enhance wellness, PharmaNutrients ( funds and supports research investigating lipids and soluble fibers. The company's activities encompass multiple technology platforms focused on creating solutions for obesity-related health issues including weight management, inflammation, diabetes and cardiovascular health. PharmaNutrients’ conjugated linoleic acid and chitosan-based products are used in a wide range of dietary supplements.

PharmaNutrients is recognized for creating Tonalin CLA, the first nutritional dietary supplement targeted at “Body Composition” and for creating the “Fat Binding” category with Absorbitol brand chitosan complex. Since its de-merger from Natural ASA of Norway in 1999, PharmaNutrients has further developed new applications for CLA beyond weight management and has filed and licensed numerous CLA and chitosan patents.

Mark Nottoli, President
PharmaNutrients, Inc.

©2005 PharmaNutrients, Inc. PharmaNutrients, CLA Tone, CLA OneDG, CLA Omega, and Omegilin are trademarks of PharmaNutrients, Inc.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.